Advances in Cancer Biology - Metastasis : Impact Factor & More
eISSN: 2667-3940
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Advances in Cancer Biology - Metastasis Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2800 |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Advances in Cancer Biology - Metastasis ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Advances in Cancer Biology - Metastasis
Histone demethylase KDM6B inhibitor GSK-J4 sensitizes glioma cells to tyrosine kinase inhibitor anlotinib in vitro by reducing PDGFRA expression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosis
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Repurposing statins in combination therapy for effective ablation of metastatic breast cancer
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Mathematical modeling of breast cancer: Analyzing immune-chemotherapy interactions and sensitivity to key parameters
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
MicroRNA 146a suppresses tumor progression and enhances therapeutic sensitivity by targeting the EGFR pathway in BRCA1-associated basal-like breast cancers
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
The roles of cancer stem cell (CSC)-derived exosomal non-coding RNAs in cancer progression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Histone demethylase KDM6B inhibitor GSK-J4 sensitizes glioma cells to tyrosine kinase inhibitor anlotinib in vitro by reducing PDGFRA expression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Alcohol-induced extracellular vesicle signatures: Exploring liquid biopsy biomarkers for early cancer detection and prognosis
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Repurposing statins in combination therapy for effective ablation of metastatic breast cancer
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
Mathematical modeling of breast cancer: Analyzing immune-chemotherapy interactions and sensitivity to key parameters
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
MicroRNA 146a suppresses tumor progression and enhances therapeutic sensitivity by targeting the EGFR pathway in BRCA1-associated basal-like breast cancers
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
The roles of cancer stem cell (CSC)-derived exosomal non-coding RNAs in cancer progression
- 1 Jul 2026
- Advances in Cancer Biology - Metastasis
FAQs on Advances in Cancer Biology - Metastasis
How many articles did Advances in Cancer Biology - Metastasis publish last year? 
Who is the publisher of Advances in Cancer Biology - Metastasis?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations